BioPharma SHAKTI aims to revolutionize biologics by promoting non-animal models for safer and more effective drug development.
Increasing diabetes prevalence, aging demographics, and adoption of skin substitutes and bioengineered tissues fuel steady growth at an 8.48% CAGR.Austin, United States, March 24, 2026 (GLOBE NEWSWIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results